The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has released the recommended child and adolescent immunization schedule for ages 18 years or younger in the United States for 2023.
The immunization schedule has been approved by CDC, the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American College of Nurse-Midwives, the American Academy of Physician Associates, and the National Association of Pediatric Nurse Practitioners.
Major changes to the child and adolescent immunization schedule for 2023 include the following:
- Recommendations for administration of the primary series in the general population and in individuals who are moderately to severely immunocompromised have been added.
- Information on booster doses, preexposure prophylaxis, and recommendations for Janssen COVID-19 vaccine recipients have also been added.
- New addition: Dengue vaccination should not be administered to children traveling to or visiting endemic dengue areas.
Hepatitis B Vaccination
- Recommendations for infants born to mothers who are hepatitis B surface antigen (HBsAg) positive, or whose HBsAg is unknown were added.
- Catch-up vaccination for persons 18 years of age: Heplisav-B® and PreHevbrio® vaccines added.
- Recommendations for the 2022-2023 influenza season were added.
- Addition to Special Situation section: Live attenuated influenza vaccines should not be administered to close contacts of immunosuppressed persons who require a protected environment.
- Recommendations for additional MMR doses in a mumps outbreak setting have been added.
Meningococcal ACWY Vaccination
- Updated to state that Menveo® one-vial (all liquid) formulation should not be administered before age 10 years.
- Recommendations for when the second or third dose of Trumenba® is administered earlier or later than the recommended minimum intervals have been added.
- Recommendations for use of 15-valent pneumococcal conjugate vaccine (PCV15) have been added.
- Recommendations for adolescents aged 18 years who are at increased risk of exposure to polioviruses have been added.
For additional guidance on the use of each vaccine appearing in the schedule, including precautions and contraindications, clinicians can view the respective ACIP vaccine recommendations at cdc.gov. In addition, vaccine catch-up guidance can be found here.
Wodi AP, Murthy N, McNally V, et al. Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger — United States, 2023. Published online February 10, 2023. MMWR. dx.doi.org/10.15585/mmwr.mm7206a1